CARLA SPERING: Open Payments
NPI 1518549096 · HALLSTEAD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 20 payments from 12 companies in 2025. Trend: 2023 $784 · 2024 $864 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $71 |
| Alnylam Pharmaceuticals Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Alkermes, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $17 |
Products named: REXULTI, AUSTEDO XR, ONPATTRO, INVEGA SUSTENNA, ARISTADA, Wegovy, PREVNAR 20, Auvelity.
Industry payments across PA — which companies pay providers there.
